Summary

The global adhesion barrier market size is projected to reach USD 1.11 billion by 2031 from USD 0.78 billion in 2026, at a CAGR of 7.3% during the forecast period. https://mnmimg.marketsandmarkets.com/Images/adhesion-barrier-market-img-overview.webp The increasing geriatric population is driving a significant rise in surgical procedures, thereby supporting the demand for adhesion barriers in modern surgical care. As individuals age, they become more prone to chronic conditions such as cardiovascular diseases, orthopedic disorders, gastrointestinal complications, and gynecological conditions, many of which require surgical intervention. Elderly patients are also at a higher risk of post-surgical complications due to slower tissue healing, reduced tissue elasticity, and increased inflammatory response, which may contribute to adhesion formation after surgery. In this context, adhesion barriers play an important role in reducing post-operative adhesions, improving surgical outcomes, and minimizing the need for repeat surgeries. As the global aging population continues to expand, the demand for adhesion barriers is expected to increase in parallel with the growing volume of complex surgical procedures. However, the high cost of advanced adhesion barrier products and limited awareness of or access to them in low-resource healthcare settings may restrict their widespread adoption. “The synthetic adhesion barrier market is projected to witness the highest growth in the market, by product, during the forecast period.” By product, the adhesion barriers market is segmented into synthetic and natural barriers. Synthetic adhesion barriers are further classified into hyaluronic acid, regenerated cellulose, polyethylene glycol, and other synthetic adhesion barriers. The higher growth of synthetic adhesion barriers can be attributed to their consistent product quality, controlled degradation profile, improved biocompatibility, and ease of formulation into films, gels, and liquids. In addition, synthetic materials offer greater manufacturing scalability and can be engineered to deliver targeted barrier performance across multiple surgical applications, thereby supporting their growing adoption in the adhesion barriers market. “General/abdominal surgeries are the largest application segment in the adhesion barrier market.” In 2025, based on application, general/abdominal surgeries held the largest share of the adhesion barriers market. The large share of this segment can be attributed to the higher risk of post-surgical adhesion formation in general/abdominal procedures, the growing volume of abdominal surgeries, and the availability of several commercialized adhesion barrier products for these procedures. Adhesions are commonly associated with abdominal and pelvic surgeries, particularly in procedures involving bowel handling, peritoneal trauma, or repeat surgical intervention. The increasing use of adhesion barriers in colorectal and other gastrointestinal surgeries, hernia repair, and other open or laparoscopic abdominal surgeries further supports the dominance of this segment. “Asia Pacific market to witness the highest growth during the forecast period” By region, the adhesion barriers market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Asia Pacific region is expected to witness the highest growth in the adhesion barriers market during the forecast period. This growth is primarily driven by improvements in healthcare infrastructure, rising healthcare expenditure, increasing disposable incomes, and expanding access to advanced surgical care in emerging economies such as China and India. The rising volume of surgical procedures, the increasing prevalence of chronic diseases, and the growing adoption of advanced surgical products are further driving demand for adhesion barriers in the region. In addition, the modernization of hospitals and surgical centers, the rapid expansion of healthcare facilities, and increasing awareness regarding the clinical and economic burden of post-surgical adhesions are contributing to market growth. The growing adoption of advanced medical technologies, along with improving purchasing capacity among healthcare providers, is expected to accelerate the use of adhesion barrier products across general/abdominal, gynecological, orthopedic, cardiovascular, and other surgical applications in the Asia Pacific. The break-up of the profile of primary participants in the adhesion barrier market: • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 – 30% • By Designation: C-level - 27%, D-level - 18%, and Others - 55% • By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and Middle East & Africa- 4% The prominent players operating in the adhesion barriers market are Johnson & Johnson (US), Baxter (US), Medtronic (Ireland), Integra LifeSciences Corporation (US), Anika Therapeutics, Inc. (US), Terumo Corporation (Japan), FzioMed, Inc. (US), MAST Biosurgery (Switzerland), BIOSCOMPASS, Inc. (US), W. L. Gore & Associates, Inc. (US), AlloSource (US), CG Bio Inc. (South Korea), PlantTec Medical GmbH (Germany), Hangzhou Singclean Medical Products Co., Ltd. (China), Gunze Limited (Japan), Samyang Biopharm Corporation (South Korea), BioRegen Biomedical (Changzhou) Co., Ltd. (China), SciVision Biotech Inc. (Taiwan), Kyeron (Netherlands), Betatech Medical (Turkey), Dongsung (South Korea), Womed (France), Proview-MBD Biotech (Taiwan), Semical (Turkey), and Alafair Biosciences (US). Research Coverage: The market study covers the adhesion barrier market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by formulation, by application, by end user, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall adhesion barrier market and the subsegments. This report will help stakeholders understand the competitive landscape and gain insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. This report provides insights into the following pointers: • Analysis of key drivers (rising geriatric population, increase in the volume of surgeries and sports-related injuries, increasing awareness about the medical implications of adhesion), restraints (reluctance of surgeons to use adhesion barriers, product recalls), opportunities (untapped emerging markets), and challenges (stringent regulations resulting in limited technological innovations) influencing the growth of the adhesion barrier market • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global adhesion barrier market. The report analyzes this market by product type, formulation, application, and region. • Product Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global adhesion barrier market • Market Development: Comprehensive information on the lucrative emerging markets by type of product, formulation, application, and region • Market Diversification: Exhaustive information about new products and services, growing geographies, recent developments, and investments in the global adhesion barrier market • Competitive Assessment: In-depth assessment of market shares, growth strategies, product and service offerings, and capabilities of leading players in the global adhesion barrier market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.2.1 PRODUCT 28
1.2.2 FORMULATION 28
1.3 MARKET SCOPE 29
1.3.1 INCLUSIONS AND EXCLUSIONS 29
1.3.2 MARKETS COVERED 30
1.3.3 YEARS CONSIDERED 31
1.4 CURRENCY 31
1.5 STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 32
2 EXECUTIVE SUMMARY 34
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 34
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 35
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 36
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 37
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 38
3 PREMIUM INSIGHTS 39
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ADHESION BARRIER MARKET 39
3.2 ADHESION BARRIER MARKET, BY REGION, 2026 VS. 2031 40
3.3 ASIA PACIFIC ADHESION BARRIER MARKET, BY FORMULATION AND COUNTRY, 2025 41
3.4 ADHESION BARRIER MARKET, BY COUNTRY 42
3.5 ADHESION BARRIER MARKET: DEVELOPING VS. DEVELOPED MARKETS 42
4 MARKET OVERVIEW 43
4.1 INTRODUCTION 43
4.2 MARKET DYNAMICS 43
4.2.1 DRIVERS 44
4.2.1.1 Rapid growth in geriatric population globally 44
4.2.1.2 Increase in volume of surgeries 45
4.2.1.3 Increasing awareness about medical implications of adhesions 46
4.2.2 RESTRAINTS 46
4.2.2.1 Reluctance of surgeons to use adhesion barriers 46
4.2.3 OPPORTUNITIES 47
4.2.3.1 Untapped markets in emerging economies 47
4.2.3.2 Growing number of hospitals 48
4.2.4 CHALLENGES 49
4.2.4.1 Stringent regulations and limited technological innovations 49
4.3 UNMET NEEDS AND WHITE SPACES 49
4.3.1 UNMET NEEDS IN ADHESION BARRIER MARKET 49
4.3.2 WHITE SPACE OPPORTUNITIES 50
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 50
4.4.1 INTERCONNECTED MARKET 50
4.4.2 CROSS-SECTOR OPPORTUNITIES 51
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 51
5 INDUSTRY TRENDS 53
5.1 PORTER'S FIVE FORCES ANALYSIS 53
5.1.1 THREAT OF NEW ENTRANTS 54
5.1.2 INTENSITY OF COMPETITIVE RIVALRY 54
5.1.3 BARGAINING POWER OF BUYERS 54
5.1.4 BARGAINING POWER OF SUPPLIERS 55
5.1.5 THREAT OF SUBSTITUTES 55
5.2 MACROECONOMICS OUTLOOK 56
5.2.1 INTRODUCTION 56
5.2.2 GDP TRENDS AND FORECAST 56
5.2.3 TRENDS IN BIOSURGERY INDUSTRY 58
5.3 SUPPLY CHAIN ANALYSIS 59
5.4 VALUE CHAIN ANALYSIS 60
5.5 ECOSYSTEM ANALYSIS 61
5.6 PRICING ANALYSIS 62
5.6.1 AVERAGE SELLING PRICE OF ADHESION BARRIER, BY PRODUCT 63
5.6.2 AVERAGE SELLING PRICE TREND OF ADHESION BARRIER, BY REGION,
2023–2025 63
5.7 TRADE ANALYSIS 64
5.7.1 IMPORT DATA FOR ADHESION BARRIER (HS CODE: 300610) 64
5.7.2 EXPORT DATA FOR ADHESION BARRIER (HS CODE: 300610) 65
5.8 KEY CONFERENCES & EVENTS, 2026–2027 65
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 66
5.10 CASE STUDY ANALYSIS 67
5.10.1 CASE STUDY 1: WORLD LAPAROSCOPY HOSPITAL DEMONSTRATES CLINICAL ADOPTION OF INTERCEED FOR POSTOPERATIVE ADHESION PREVENTION IN LAPAROSCOPIC SURGERY 67
5.10.2 CASE STUDY 2: BUDDHIST TZU CHI GENERAL HOSPITAL ACHIEVES HIGH SEPRAFILM PLACEMENT SUCCESS USING A MODIFIED LAPAROSCOPIC APPLICATION TECHNIQUE 67
5.10.3 CASE STUDY 3: FUKUSHIMA MEDICAL UNIVERSITY DEMONSTRATES SAFE AND RELIABLE LAPAROSCOPIC APPLICATION OF SEPRAFILM USING A REDUCER SLEEVE TECHNIQUE 68
5.11 IMPACT OF 2025 US TARIFFS ON ADHESION BARRIER MARKET 68
5.11.1 INTRODUCTION 68
5.11.2 KEY TARIFF RATES 69
5.11.3 PRICE IMPACT ANALYSIS 70
5.11.4 IMPACT ON REGION 70
5.11.4.1 US 70
5.11.4.2 Europe 70
5.11.4.3 Asia Pacific 71
5.11.5 IMPACT ON END-USE INDUSTRIES 71
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT,
PATENTS, AND INNOVATIONS 72
6.1 KEY EMERGING TECHNOLOGIES 72
6.2 COMPLEMENTARY TECHNOLOGIES 72
6.2.1 HYDROGEL BIOMATERIALS 72
6.3 TECHNOLOGY/PRODUCT ROADMAP 73
6.3.1 SHORT-TERM (2025-2027) | FOUNDATION & EARLY COMMERCIALIZATION 73
6.3.2 MID-TERM (2027-2030) | EXPANSION & STANDARDIZATION 73
6.3.3 LONG-TERM (2030-2035+) | MASS COMMERCIALIZATION & DISRUPTION 74
6.4 PATENT ANALYSIS 74
6.4.1 PATENT PUBLICATION TRENDS FOR ADHESION BARRIER MARKET 74
6.4.2 TOP APPLICANTS (COMPANIES) OF ADHESION BARRIER PATENTS 75
6.4.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ADHESION BARRIER MARKET 76
6.4.4 LIST OF MAJOR PATENTS 76
6.5 IMPACT OF AI/GEN AI ON ADHESION BARRIER MARKET 77
6.5.1 TOP USE CASES AND MARKET POTENTIAL 78
6.5.2 TOP CASE STUDIES OF AI IMPLEMENTATION IN ADHESION BARRIER MARKET 79
6.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT
ON MARKET PLAYERS 79
6.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN ADHESION
BARRIER MARKET 80
6.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 81
6.6.1 BAXTER: SEPRAFILM - EVIDENCE-BACKED ADHESION REDUCTION IN ABDOMINAL & PELVIC SURGERY 81
6.6.2 JOHNSON & JOHNSON MEDTECH/ETHICON: GYNECARE INTERCEED - STANDARDIZED ADHESION PREVENTION IN GYNECOLOGIC SURGERY 81
6.6.3 ANIKA THERAPEUTICS/HYALOBARRIER: HYALURONIC ACID GEL FOR LAPAROSCOPY, LAPAROTOMY & HYSTEROSCOPY 81
7 TREATMENT AND REGULATORY LANDSCAPE 82
7.1 REGIONAL REGULATIONS AND COMPLIANCE 82
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
7.1.2 INDUSTRY STANDARDS 84
7.1.2.1 North America 84
7.1.2.1.1 US 84
7.1.2.1.2 Canada 85
7.1.2.2 Europe 85
7.1.2.3 Asia Pacific 86
7.1.2.3.1 China 86
7.1.2.3.2 Japan 87
7.1.2.3.3 India 87
7.1.2.4 Latin America 88
7.1.2.4.1 Brazil 88
7.1.2.4.2 Mexico 88
7.1.2.5 Middle East 88
7.1.2.6 Africa 88
7.2 CERTIFICATIONS, LABELLING, AND ECO-STANDARDS 89
7.2.1 CERTIFICATIONS, LABELLING, AND ECO-STANDARDS IN
ADHESION BARRIER MARKET 89
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 90
8.1 DECISION-MAKING PROCESS 90
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 90
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
8.2.2 KEY BUYING CRITERIA 91
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 92
8.4 UNMET NEEDS IN END USERS 93
8.5 MARKET PROFITABILITY 93
8.5.1 REVENUE POTENTIAL 93
8.5.2 COST DYNAMICS 94
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 94
9 ADHESION BARRIER MARKET, BY PRODUCT 95
9.1 INTRODUCTION 96
9.2 SYNTHETIC ADHESION BARRIERS 96
9.2.1 HYALURONIC ACID 99
9.2.1.1 Greater biocompatibility and higher bioresorbability to drive segment 99
9.2.2 REGENERATED CELLULOSE 100
9.2.2.1 Non-reactive and bacteriostatic nature of regenerated cellulose to drive use in gynecological surgeries 100
9.2.3 POLYETHYLENE GLYCOL 101
9.2.3.1 Ability to decrease post-surgical adhesions after abdominal and peritoneal surgeries to drive segment 101
9.2.4 OTHER SYNTHETIC ADHESION BARRIERS 103
9.3 NATURAL ADHESION BARRIERS 104
9.3.1 TIME-CONSUMING AND COMPLEX APPLICATIONS DURING SURGERIES TO LIMIT MARKET 104
10 ADHESION BARRIER MARKET, BY FORMULATION 106
10.1 INTRODUCTION 107
10.2 FILM FORMULATIONS 108
10.2.1 FILM FORMULATIONS DOMINATED ADHESION BARRIER MARKET IN 2025 108
10.3 GEL FORMULATIONS 110
10.3.1 HIGHER PREFERENCE FOR GEL-BASED FORMULATIONS OVER FILM-BASED BARRIERS TO DRIVE MARKET 110
10.4 LIQUID FORMULATIONS 111
10.4.1 LIQUID FORMULATIONS TO BE WIDELY USED IN GYNECOLOGICAL,
PELVIC, AND ABDOMINAL SURGERIES 111
11 ADHESION BARRIER MARKET, BY APPLICATION 113
11.1 INTRODUCTION 114
11.2 GYNECOLOGICAL SURGERIES 114
11.2.1 RISING INCIDENCE OF PELVIC AND UTERINE CANCER AND INCREASING NUMBER OF C-SECTIONS TO DRIVE MARKET 114
11.3 GENERAL/ABDOMINAL SURGERIES 117
11.3.1 INCREASING FORMATION OF POST-OPERATIVE ADHESIONS AND RISING COMPLICATIONS AMONG PATIENTS TO DRIVE MARKET 117
11.4 CARDIOVASCULAR SURGERIES 118
11.4.1 HIGH NUMBER OF CONGENITAL HEART DISEASE PATIENTS TO DRIVE MARKET 118
11.5 ORTHOPEDIC SURGERIES 119
11.5.1 GROWING VOLUME OF ORTHOPEDIC PROCEDURES TO DRIVE MARKET 119
11.6 NEUROLOGICAL SURGERIES 120
11.6.1 GROWING CONCERNS ABOUT PHYSICAL PAIN AND IMPAIRMENT AFTER NEUROLOGICAL SURGERIES TO DRIVE MARKET 120
11.7 RECONSTRUCTIVE SURGERIES 122
11.7.1 HIGHER INSURANCE COVERAGE FOR COSMETIC SURGERIES TO DRIVE MARKET 122
11.8 UROLOGICAL SURGERIES 123
11.8.1 GROWING INCIDENCE OF POST-OPERATIVE ADHESION FORMATION TO DRIVE MARKET 123
11.9 OTHER SURGERIES 124
12 ADHESION BARRIER MARKET, BY END USER 125
12.1 INTRODUCTION 126
12.2 HOSPITALS AND CLINICS 126
12.2.1 INCREASING INVESTMENT IN HOSPITALS TO DRIVE MARKET 126
12.3 AMBULATORY SURGICAL CENTERS 127
12.3.1 INCREASING NUMBER OF OUTPATIENT VISITS AND FAVORABLE REIMBURSEMENT POLICIES TO DRIVE MARKET 127
12.4 OTHER END USERS 129
13 ADHESION BARRIER MARKET, BY REGION 130
13.1 INTRODUCTION 131
13.2 NORTH AMERICA 132
13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 133
13.2.2 US 136
13.2.2.1 US dominated North American adhesion barrier market in 2025 136
13.2.3 CANADA 139
13.2.3.1 Increasing number of C-section surgeries to drive market 139
13.3 EUROPE 141
13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 142
13.3.2 GERMANY 145
13.3.2.1 Growth in healthcare spending to drive market 145
13.3.3 FRANCE 147
13.3.3.1 Rising number of advanced orthopedic surgeries to drive market 147
13.3.4 UK 150
13.3.4.1 Rising number of cardiovascular, gynecological, and orthopedic surgeries to drive market 150
13.3.5 ITALY 152
13.3.5.1 Rising geriatric population and increasing prevalence of chronic diseases to drive market 152
13.3.6 SPAIN 155
13.3.6.1 High cost of surgical procedures to limit market 155
13.3.7 REST OF EUROPE 158
13.4 ASIA PACIFIC 161
13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 162
13.4.2 JAPAN 164
13.4.2.1 Rising geriatric population and increasing number of surgical procedures performed to drive market 164
13.4.3 CHINA 167
13.4.3.1 Growing number of hospitals and healthcare policy reforms to drive growth 167
13.4.4 INDIA 170
13.4.4.1 Rising focus of multinational companies on Indian market and improving urban healthcare infrastructure to drive market 170
13.4.5 AUSTRALIA 172
13.4.5.1 Growing government awareness campaigns and rising funding and grants for medical research to drive market 172
13.4.6 SOUTH KOREA 175
13.4.6.1 Growing geriatric population to drive market 175
13.4.7 REST OF ASIA PACIFIC 177
13.5 LATIN AMERICA 180
13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 180
13.5.2 BRAZIL 183
13.5.2.1 Well-established healthcare system to drive sustained growth in market 183
13.5.3 MEXICO 186
13.5.3.1 Rising chronic diseases and well-organized healthcare system to drive market 186
13.5.4 REST OF LATIN AMERICA 188
13.6 MIDDLE EAST & AFRICA 191
13.6.1 STRENGTHENING OF HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH 191
13.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 191
13.6.3 GCC COUNTRIES 194
13.6.4 REST OF MIDDLE EAST & AFRICA 196
14 COMPETITIVE LANDSCAPE 200
14.1 INTRODUCTION 200
14.2 KEY PLAYER STRATEGY/RIGHT TO WIN 200
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ADHESION BARRIER MARKET 200
14.3 REVENUE ANALYSIS, 2021–2025 202
14.4 MARKET SHARE ANALYSIS, 2025 203
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 204
14.5.1 STARS 204
14.5.2 EMERGING LEADERS 204
14.5.3 PERVASIVE PLAYERS 205
14.5.4 PARTICIPANTS 205
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 206
14.5.5.1 Company footprint 206
14.5.5.2 Region footprint 207
14.5.5.3 Product footprint 208
14.5.5.4 Application footprint 209
14.5.5.5 Formulation footprint 210
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 211
14.6.1 PROGRESSIVE COMPANIES 211
14.6.2 RESPONSIVE COMPANIES 211
14.6.3 DYNAMIC COMPANIES 211
14.6.4 STARTING BLOCKS 211
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 213
14.7 BRAND/PRODUCT COMPARISON 214
14.8 COMPANY VALUATION AND FINANCIAL METRICS 215
14.8.1 FINANCIAL METRICS 215
14.8.2 COMPANY VALUATION 215
14.9 COMPETITIVE SCENARIO 216
14.9.1 PRODUCT LAUNCHES AND APPROVALS 216
14.9.2 DEALS 216
14.9.3 EXPANSIONS 217
14.9.4 OTHER DEVELOPMENTS 217
15 COMPANY PROFILES 218
15.1 KEY PLAYERS 218
15.1.1 BAXTER 218
15.1.1.1 Business overview 218
15.1.1.2 Products offered 219
15.1.1.3 Recent developments 220
15.1.1.3.1 Other developments 220
15.1.1.4 MnM view 220
15.1.1.4.1 Key strengths 220
15.1.1.4.2 Strategic choices 220
15.1.1.4.3 Weaknesses and competitive threats 221
15.1.2 JOHNSON & JOHNSON 222
15.1.2.1 Business overview 222
15.1.2.2 Products offered 223
15.1.2.3 Recent developments 224
15.1.2.3.1 DEALS 224
15.1.2.3.2 Other developments 224
15.1.2.4 MnM view 224
15.1.2.4.1 Key strengths 224
15.1.2.4.2 Strategic choices 225
15.1.2.4.3 Weaknesses and competitive threats 225
15.1.3 INTEGRA LIFESCIENCES CORPORATION 226
15.1.3.1 Business overview 226
15.1.3.2 Products offered 227
15.1.3.3 Recent developments 228
15.1.3.3.1 Other developments 228
15.1.3.4 MnM view 228
15.1.3.4.1 Key strengths 228
15.1.3.4.2 Strategic choices 228
15.1.3.4.3 Weaknesses and competitive threats 228
15.1.4 TERUMO CORPORATION 229
15.1.4.1 Business overview 229
15.1.4.2 Products offered 230
15.1.4.3 Recent developments 231
15.1.4.3.1 Deals 231
15.1.4.3.2 Expansions 231
15.1.4.3.3 Other developments 232
15.1.4.4 MnM view 232
15.1.4.4.1 Key strengths 232
15.1.4.4.2 Strategic choices 232
15.1.4.4.3 Weaknesses and competitive threats 232
15.1.5 FZIOMED, INC. 233
15.1.5.1 Business overview 233
15.1.5.2 Products offered 233
15.1.5.3 Recent developments 234
15.1.5.3.1 Product launches and approvals 234
15.1.5.4 MnM view 234
15.1.5.4.1 Key strengths 234
15.1.5.4.2 Strategic choices 234
15.1.5.4.3 Weaknesses and competitive threats 235
15.1.6 ANIKA THERAPEUTICS INC. 236
15.1.6.1 Business overview 236
15.1.6.2 Products offered 237
15.1.6.3 Recent developments 238
15.1.6.3.1 Other developments 238
15.1.7 MAST BIOSURGERY 239
15.1.7.1 Business overview 239
15.1.7.2 Products offered 239
15.1.8 BETATECH MEDICAL 240
15.1.8.1 Business overview 240
15.1.8.2 Products offered 240
15.1.9 DONGSUNG 241
15.1.9.1 Business overview 241
15.1.10 PRODUCTS OFFERED 242
15.1.11 BIOSCOMPASS, INC. 243
15.1.11.1 Business overview 243
15.1.11.2 Products offered 243
15.1.12 W.L. GORE & ASSOCIATES, INC. 244
15.1.12.1 Business overview 244
15.1.12.2 Products offered 244
15.1.13 ALLOSOURCE 245
15.1.13.1 Business overview 245
15.1.13.2 Products offered 245
15.1.14 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD 246
15.1.14.1 Business overview 246
15.1.14.2 Products offered 246
15.1.15 BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. 247
15.1.15.1 Business overview 247
15.1.15.2 Products offered 247
15.1.16 DALIM TISSEN CO., LTD. 248
15.1.16.1 Business overview 248
15.1.16.2 Products offered 248
15.2 OTHER PLAYERS 249
15.2.1 CG BIO INC. 249
15.2.2 PLANTTEC MEDICAL GMBH 250
15.2.3 GUNZE LIMITED 251
15.2.4 SAMYANG BIOPHARM CORPORATION 252
15.2.5 WOMED 252
15.2.6 PROVIEW-MBD BIOTECH CO., LTD 253
15.2.7 SEMICAL 254
15.2.8 ALAFAIR BIOSCIENCES 254
15.2.9 SCIVISION BIOTECH INC. 255
15.2.10 KYERON 255
16 RESEARCH METHODOLOGY 256
16.1 RESEARCH DATA 256
16.1.1 SECONDARY DATA 256
16.1.1.1 Key data from secondary sources 258
16.1.2 PRIMARY DATA 258
16.1.2.1 Key data from primary sources 259
16.1.2.2 Key industry insights 260
16.2 MARKET SIZE ESTIMATION 260
16.2.1 BOTTOM-UP APPROACH 260
16.2.2 TOP-DOWN APPROACH 261
16.2.3 BASE NUMBER ESTIMATION 261
16.2.3.1 Supply-side Analysis (Revenue Share Analysis) 261
16.2.3.2 Company Presentations and Primary Interviews 263
16.2.3.3 Demand-side Analysis 263
16.3 MARKET FORECAST APPROACH 264
16.4 MARKET BREAKDOWN AND DATA TRIANGULATION 266
16.5 MARKET SHARE ESTIMATION 266
16.6 STUDY ASSUMPTIONS 267
16.7 FACTOR ANALYSIS 268
16.8 RESEARCH LIMITATIONS 268
16.8.1 SCOPE-RELATED LIMITATIONS 268
16.8.2 METHODOLOGY-RELATED LIMITATIONS 268
16.9 RISK ASSESSMENT 269
17 APPENDIX 270
17.1 DISCUSSION GUIDE 270
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 274
17.3 CUSTOMIZATION OPTIONS 276
17.4 RELATED REPORTS 276
17.5 AUTHOR DETAILS 277

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES 31
TABLE 2 GERIATRIC POPULATION GROWTH RATE, BY REGION, 2020–2050 44
TABLE 3 LIST OF COMMON SPECIALTIES AND PROCEDURES IN OLDER ADULTS 45
TABLE 4 US: PERCENTAGE INCREASE IN NUMBER OF SURGICAL PROCEDURES PERFORMED (2010 VS. 2020) 46
TABLE 5 PER CAPITA NATIONAL INCOME (USD) 47
TABLE 6 ADHESION BARRIER MARKET: IMPACT OF PORTER'S FIVE FORCES ANALYSIS 55
TABLE 7 GDP PERCENTAGE CHANGE, BY KEY COUNTRIES, 2021–2030 56
TABLE 8 ADHESION BARRIER MARKET: ROLE OF COMPANIES IN ECOSYSTEM 62
TABLE 9 AVERAGE SELLING PRICE OF ADHESION BARRIER, BY PRODUCT, 2025 63
TABLE 10 AVERAGE SELLING PRICE TREND OF ADHESION BARRIER PRODUCTS,
BY REGION, 2023–2025 63
TABLE 11 IMPORT DATA FOR ADHESION BARRIER (HS CODE: 300610), BY COUNTRY,
2021–2025 (USD THOUSAND) 64
TABLE 12 EXPORT DATA FOR ADHESION BARRIER (HS CODE: 300610), BY COUNTRY,
2021–2025 (USD THOUSAND) 65
TABLE 13 ADHESION BARRIER MARKET: LIST OF KEY CONFERENCES & EVENTS, 2026–2027 65
TABLE 14 US-ADJUSTED RECIPROCAL TARIFF RATES 69
TABLE 15 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ADHESIVE BARRIER PRODUCTS 69
TABLE 16 ADHESION BARRIER MARKET: LIST OF MAJOR PATENTS 76
TABLE 17 TOP USE CASES AND MARKET POTENTIAL 78
TABLE 18 ADHESION BARRIER MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION 79
TABLE 19 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 79
TABLE 21 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 82
TABLE 22 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 23 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 25 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 85
TABLE 26 NMPA MEDICAL DEVICE CLASSIFICATION 86
TABLE 27 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY IN JAPAN 87
TABLE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR KEY END USERS 91
TABLE 29 KEY BUYING CRITERIA FOR END USERS 91
TABLE 30 ADOPTION BARRIERS & INTERNAL CHALLENGES 92
TABLE 31 ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 96
TABLE 32 KEY BRANDS OF SYNTHETIC ADHESION BARRIERS 96
TABLE 33 SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 97
TABLE 34 SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 98
TABLE 35 SYNTHETIC ADHESION BARRIERS MARKET, BY REGION,
2024–2031 (MILLION UNITS) 98
TABLE 36 HYALURONIC ACID MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 99
TABLE 37 REGENERATED CELLULOSE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 101
TABLE 38 POLYETHYLENE GLYCOL MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 102
TABLE 39 OTHER SYNTHETIC ADHESION BARRIERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 103
TABLE 40 LIST OF NATURAL ADHESION BARRIERS AVAILABLE 104
TABLE 41 NATURAL ADHESION BARRIERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 105
TABLE 42 NATURAL ADHESION BARRIERS MARKET, BY REGION,
2024–2031 (MILLION UNITS) 105
TABLE 43 ADOPTION OF DIFFERENT ADHESION BARRIER FORMULATIONS IN SURGERIES 107
TABLE 44 ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 107
TABLE 45 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH FILM FORMULATIONS 108
TABLE 46 ADHESION BARRIER MARKET FOR FILM FORMULATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 109
TABLE 47 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH GEL FORMULATIONS 110
TABLE 48 ADHESION BARRIER MARKET FOR GEL FORMULATIONS, BY COUNTRY/REGION, 2024–2031 (USD MILLION) 111
TABLE 49 INDICATIVE LIST OF COMMERCIALLY AVAILABLE ADHESION BARRIERS WITH LIQUID FORMULATIONS 112
TABLE 50 ADHESION BARRIER MARKET FOR LIQUID FORMULATIONS, BY COUNTRY 2024–2031 (USD MILLION) 112
TABLE 51 ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 114
TABLE 52 PREVALENCE OF INTRAUTERINE ADHESIONS ACROSS DIFFERENT GYNECOLOGICAL PROCEDURES (IN %) 115
TABLE 53 COUNTRIES WITH HIGHEST C-SECTION RATES (2022) 115
TABLE 54 ADHESION BARRIER MARKET FOR GYNECOLOGICAL SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION) 116
TABLE 55 ADHESION BARRIER MARKET FOR GENERAL/ABDOMINAL SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION) 117
TABLE 56 ADHESION BARRIER MARKET FOR CARDIOVASCULAR SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION) 118
TABLE 57 ADHESION BARRIER MARKET FOR ORTHOPEDIC SURGERIES, BY COUNTRY,
2024–2031 (USD MILLION) 119
TABLE 58 ADHESION BARRIER MARKET FOR NEUROLOGICAL SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION) 121
TABLE 59 ADHESION BARRIER MARKET FOR RECONSTRUCTIVE SURGERIES, BY COUNTRY, 2024–2031 (USD MILLION) 122
TABLE 60 ADHESION BARRIER MARKET FOR UROLOGICAL SURGERIES, BY COUNTRY,
2024–2031 (USD MILLION) 123
TABLE 61 ADHESION BARRIER MARKET FOR OTHER SURGERIES, BY COUNTRY,
2024–2031 (USD MILLION) 124
TABLE 62 ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 126
TABLE 63 ADHESION BARRIER MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY,
2024–2031 (USD MILLION) 127
TABLE 64 ADHESION BARRIER MARKET FOR AMBULATORY SURGICAL CENTERS,
BY COUNTRY, 2024–2031 (USD MILLION) 128
TABLE 65 ADHESION BARRIER MARKET FOR OTHER END USERS, BY COUNTRY,
2024–2031 (USD MILLION) 129
TABLE 66 ADHESION BARRIER MARKET, BY REGION, 2024–2031 (USD MILLION) 132
TABLE 67 US: CUMULATIVE PROCEDURAL VOLUME, 2012-2023 (N = 3,715,320) 132
TABLE 68 NORTH AMERICA: ADHESION BARRIER MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 134
TABLE 69 NORTH AMERICA: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 134
TABLE 70 NORTH AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 134
TABLE 71 NORTH AMERICA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 135
TABLE 72 NORTH AMERICA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 135
TABLE 73 NORTH AMERICA: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 136
TABLE 74 US: MACROECONOMIC INDICATORS 137
TABLE 75 US: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 137
TABLE 76 US: SYNTHETIC ADHESION BARRIER MARKET, BY TYPE,
2024–2031 (USD MILLION) 137
TABLE 77 US: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 138
TABLE 78 US: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 138
TABLE 79 US: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 138
TABLE 80 CANADA: MACROECONOMIC INDICATORS 139
TABLE 81 CANADA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 139
TABLE 82 CANADA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 140
TABLE 83 CANADA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 140
TABLE 84 CANADA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 141
TABLE 85 CANADA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 141
TABLE 86 EUROPEAN COUNTRIES WITH HIGHEST C-SECTION RATE (2021) 142
TABLE 87 EUROPE: ADHESION BARRIER MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 143
TABLE 88 EUROPE: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 143
TABLE 89 EUROPE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 143
TABLE 90 EUROPE: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 144
TABLE 91 EUROPE: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 144
TABLE 92 EUROPE: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 144
TABLE 93 GERMANY: MACROECONOMIC INDICATORS 145
TABLE 94 GERMANY: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 145
TABLE 95 GERMANY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 146
TABLE 96 GERMANY: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 146
TABLE 97 GERMANY: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 146
TABLE 98 GERMANY: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 147
TABLE 99 SURGICAL PROCEDURES PERFORMED IN FRANCE, 2021 147
TABLE 100 FRANCE: KEY MACROECONOMIC INDICATORS 148
TABLE 101 FRANCE: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 148
TABLE 102 FRANCE: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 148
TABLE 103 FRANCE: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 149
TABLE 104 FRANCE: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 149
TABLE 105 FRANCE: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 149
TABLE 106 UK: KEY MACROECONOMIC INDICATORS 150
TABLE 107 UK: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 151
TABLE 108 UK: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 151
TABLE 109 UK: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 151
TABLE 110 UK: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 152
TABLE 111 UK: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 152
TABLE 112 ITALY: KEY MACROECONOMIC INDICATORS 153
TABLE 113 ITALY: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 153
TABLE 114 ITALY: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 154
TABLE 115 ITALY: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 154
TABLE 116 ITALY: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 154
TABLE 117 ITALY: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 155
TABLE 118 SURGICAL PROCEDURES PERFORMED IN SPAIN, 2021 156
TABLE 119 SPAIN: KEY MACROECONOMIC INDICATORS 156
TABLE 120 SPAIN: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 156
TABLE 121 SPAIN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 156
TABLE 122 SPAIN: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 157
TABLE 123 SPAIN: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 157
TABLE 124 SPAIN: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 157
TABLE 125 REST OF EUROPE: PERCENTAGE OF GDP ON HEALTHCARE EXPENDITURE,
BY COUNTRY 158
TABLE 126 REST OF EUROPE: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 158
TABLE 127 REST OF EUROPE: SYNTHETIC ADHESION BARRIERS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 159
TABLE 128 REST OF EUROPE: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 159
TABLE 129 REST OF EUROPE: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 160
TABLE 130 REST OF EUROPE: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 160
TABLE 131 ASIA PACIFIC: ADHESION BARRIER MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 162
TABLE 132 ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 162
TABLE 133 ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 163
TABLE 134 ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 163
TABLE 135 ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 164
TABLE 136 ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 164
TABLE 137 JAPAN: KEY MACROECONOMIC INDICATORS 165
TABLE 138 JAPAN: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 165
TABLE 139 JAPAN: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 166
TABLE 140 JAPAN: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 166
TABLE 141 JAPAN: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 166
TABLE 142 JAPAN: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 167
TABLE 143 CHINA: KEY MACROECONOMIC INDICATORS 168
TABLE 144 CHINA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 168
TABLE 145 CHINA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 168
TABLE 146 CHINA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 169
TABLE 147 CHINA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 169
TABLE 148 CHINA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 169
TABLE 149 INDIA: KEY MACROINDICATORS 170
TABLE 150 INDIA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 171
TABLE 151 INDIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 171
TABLE 152 INDIA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 171
TABLE 153 INDIA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172
TABLE 154 INDIA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 172
TABLE 155 AUSTRALIA: KEY MACROINDICATORS 173
TABLE 156 AUSTRALIA: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 173
TABLE 157 AUSTRALIA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 173
TABLE 158 AUSTRALIA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 174
TABLE 159 AUSTRALIA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 174
TABLE 160 AUSTRALIA: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 174
TABLE 161 SOUTH KOREA: KEY MACROINDICATORS 175
TABLE 162 SOUTH KOREA: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 175
TABLE 163 SOUTH KOREA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 176
TABLE 164 SOUTH KOREA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 176
TABLE 165 SOUTH KOREA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 177
TABLE 166 SOUTH KOREA: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 177
TABLE 167 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 178
TABLE 168 REST OF ASIA PACIFIC: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 178
TABLE 169 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 179
TABLE 170 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 179
TABLE 171 REST OF ASIA PACIFIC: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 180
TABLE 172 LATIN AMERICA: ADHESION BARRIER MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 181
TABLE 173 LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 181
TABLE 174 LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 181
TABLE 175 LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 182
TABLE 176 LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 182
TABLE 177 LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 183
TABLE 178 BRAZIL: KEY MACROINDICATORS 184
TABLE 179 BRAZIL: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 184
TABLE 180 BRAZIL: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 184
TABLE 181 BRAZIL: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 185
TABLE 182 BRAZIL: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 185
TABLE 183 BRAZIL: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 185
TABLE 184 MEXICO: KEY MACROINDICATORS 186
TABLE 185 MEXICO: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 186
TABLE 186 MEXICO: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 187
TABLE 187 MEXICO: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 187
TABLE 188 MEXICO: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 187
TABLE 189 MEXICO: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 188
TABLE 190 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 188
TABLE 191 REST OF LATIN AMERICA: SYNTHETIC ADHESION BARRIERS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 189
TABLE 192 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 189
TABLE 193 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 190
TABLE 194 REST OF LATIN AMERICA: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 190
TABLE 195 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 192
TABLE 196 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 192
TABLE 197 MIDDLE EAST & AFRICA: SYNTHETIC ADHESION BARRIERS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 192
TABLE 198 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 193
TABLE 199 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 193
TABLE 200 MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 194
TABLE 201 GCC COUNTRIES: ADHESION BARRIER MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 194
TABLE 202 GCC COUNTRIES: SYNTHETIC ADHESION BARRIERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 195
TABLE 203 GCC COUNTRIES: ADHESION BARRIER MARKET, BY FORMULATION,
2024–2031 (USD MILLION) 195
TABLE 204 GCC COUNTRIES: ADHESION BARRIER MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 196
TABLE 205 GCC COUNTRIES: ADHESION BARRIER MARKET, BY END USER,
2024–2031 (USD MILLION) 196
TABLE 206 REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 197
TABLE 207 REST OF MIDDLE EAST & AFRICA: SYNTHETIC ADHESION BARRIERS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 197
TABLE 208 REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY FORMULATION, 2024–2031 (USD MILLION) 198
TABLE 209 REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 198
TABLE 210 REST OF MIDDLE EAST & AFRICA: ADHESION BARRIER MARKET, BY END USER, 2024–2031 (USD MILLION) 199
TABLE 211 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN
ADHESION BARRIER MARKET 200
TABLE 212 ADHESION BARRIER MARKET: DEGREE OF COMPETITION 203
TABLE 213 ADHESIVE BARRIER MARKET: REGION FOOTPRINT 207
TABLE 214 ADHESIVE BARRIER MARKET: PRODUCT FOOTPRINT 208
TABLE 215 ADHESIVE BARRIER MARKET: APPLICATION FOOTPRINT 209
TABLE 216 ADHESIVE BARRIER MARKET: FORMULATION FOOTPRINT 210
TABLE 217 ADHESION BARRIER MARKET: DETAILED LIST OF KEY STARTUPS/SMES 213
TABLE 218 ADHESION BARRIER MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 213
TABLE 219 ADHESIVE BARRIER MARKET: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2022– MAY 2026 216
TABLE 220 ADHESIVE BARRIER MARKET: DEALS, JANUARY 2022–MAY 2026 216
TABLE 221 ADHESIVE BARRIER MARKET: EXPANSIONS, JANUARY 2022–MAY 2026 217
TABLE 222 ADHESIVE BARRIER MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 217
TABLE 223 BAXTER: COMPANY OVERVIEW 218
TABLE 224 BAXTER: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 220
TABLE 225 JOHNSON & JOHNSON: COMPANY OVERVIEW 222
TABLE 226 JOHNSON & JOHNSON: DEALS, JANUARY 2022–MAY 2026 224
TABLE 227 JOHNSON & JOHNSON: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 224
TABLE 228 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 226
TABLE 229 INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022–MAY 2026 228
TABLE 230 TERUMO CORPORATION: COMPANY OVERVIEW 229
TABLE 231 TERUMO CORPORATION: DEALS, JANUARY 2022–MAY 2026 231
TABLE 232 TERUMO CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2026 231
TABLE 233 TERUMO CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 232
TABLE 234 FZIOMED, INC.: COMPANY OVERVIEW 233
TABLE 235 FZIOMED, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026 234
TABLE 236 ANIKA THERAPEUTICS INC.: COMPANY OVERVIEW 236
TABLE 237 ANIKA THERAPEUTICS INC.: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2026 238
TABLE 238 MAST BIOSURGERY: COMPANY OVERVIEW 239
TABLE 239 BETATECH MEDICAL: COMPANY OVERVIEW 240
TABLE 240 DONGSUNG: COMPANY OVERVIEW 241
TABLE 241 BIOSCOMPASS, INC.: COMPANY OVERVIEW 243
TABLE 242 W. L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 244
TABLE 243 ALLOSOURCE: COMPANY OVERVIEW 245
TABLE 244 HANGZHOU SINGCLEAN MEDICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW 246
TABLE 245 BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.: COMPANY OVERVIEW 247
TABLE 246 DALIM TISSEN CO., LTD.: COMPANY OVERVIEW 248
TABLE 247 RISK ASSESSMENT: ADHESION BARRIER MARKET 269
FIGURE 1 KEY INSIGHTS & MARKET HIGHLIGHTS 34
FIGURE 2 ADHESION BARRIER MARKET, BY PRODUCT, 2026–2031 35
FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ADHESION BARRIER MARKET 35
FIGURE 4 DISRUPTIVE TRENDS IMPACTING GROWTH OF ADHESION BARRIER MARKET 36
FIGURE 5 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN
ADHESION BARRIER MARKET, 2025 37
FIGURE 6 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 38
FIGURE 7 INCREASING VOLUME OF SURGERIES AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH 39
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40
FIGURE 9 FILM FORMULATION SEGMENT TO ACCOUNT FOR LARGEST MARKET
SHARE IN 2025 41
FIGURE 10 INDIA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031 42
FIGURE 11 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH
DURING FORECAST PERIOD 42
FIGURE 12 ADHESION BARRIER MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 43
FIGURE 13 ADHESION BARRIER MARKET: PORTER'S FIVE FORCES ANALYSIS 53
FIGURE 14 ADHESION BARRIER MARKET: SUPPLY CHAIN ANALYSIS 59
FIGURE 15 ADHESION BARRIER MARKET: VALUE CHAIN ANALYSIS 60
FIGURE 16 ADHESION BARRIER MARKET: ECOSYSTEM ANALYSIS 61
FIGURE 17 REVENUE SHIFTS & NEW REVENUE POCKETS IN ADHESION BARRIER MARKET 66
FIGURE 18 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) IN ADHESION BARRIER (2015–2025) 75
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR ADHESION BARRIER PATENTS, 2015–2025 76
FIGURE 20 CE APPROVAL PROCESS IN EUROPE FOR BIOSURGERY PRODUCTS 86
FIGURE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN KEY END USERS 90
FIGURE 22 KEY BUYING CRITERIA FOR KEY END USERS 91
FIGURE 23 ADHESION BARRIER MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 131
FIGURE 24 NORTH AMERICA: ADHESION BARRIER MARKET SNAPSHOT 133
FIGURE 25 ASIA PACIFIC: ADHESION BARRIER MARKET SNAPSHOT 161
FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS IN ADHESION BARRIER
MARKET (2021−2025) 202
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ADHESION
BARRIER MARKET (2025) 203
FIGURE 28 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 205
FIGURE 29 ADHESIVE BARRIER MARKET: COMPANY FOOTPRINT 206
FIGURE 30 ADHESION BARRIER MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2025 212
FIGURE 31 ADHESION BARRIER MARKET: BRAND/PRODUCT COMPARISON 214
FIGURE 32 EV/EBITDA OF KEY VENDORS 215
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDOR 215
FIGURE 34 BAXTER: COMPANY SNAPSHOT (2025) 219
FIGURE 35 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025) 223
FIGURE 36 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2025) 227
FIGURE 37 TERUMO CORPORATION: COMPANY SNAPSHOT (2025) 230
FIGURE 38 ANIKA THERAPEUTICS INC.: COMPANY SNAPSHOT (2025) 237
FIGURE 39 DONGSUNG: COMPANY SNAPSHOT (2025) 241
FIGURE 40 RESEARCH DESIGN 256
FIGURE 41 PRIMARY SOURCES 258
FIGURE 42 BOTTOM-UP APPROACH 261
FIGURE 43 TOP-DOWN APPROACH 261
FIGURE 44 SUPPLY-SIDE ADHESION BARRIER MARKET SIZE ESTIMATION:
REVENUE SHARE ANALYSIS 262
FIGURE 45 REVENUE SHARE ANALYSIS ILLUSTRATION: BAXTER INTERNATIONAL 262
FIGURE 46 SUPPLY-SIDE ANALYSIS: ADHESION BARRIER MARKET (2025) 263
FIGURE 47 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 264
FIGURE 48 DATA TRIANGULATION METHODOLOGY 266